Novavax Completes First Stage Enrollment In Pivotal H1N1 Influenza Vaccine Study
Novavax has completed the enrollment in the first stage of a two-stage clinical study of its novel 2009 H1N1 virus-like-particle (VLP) pandemic influenza unadjuvanted vaccine in the country
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.